RiverVest Venture Fund III, L.P. → OnKure Therapeutics, Inc. OKUR

Stake: 1.55% Shares: 196,198 CUSIP: 75974E103 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 5.79

1,181,591 shares short · +34.5% vs prior

Post-Filing Returns · since 2025-01-16 on OKUR

+1 day

-3.7%

+5 days

-1.8%

+30 days

-5.3%

+60 days

-19.8%

+90 days

-51.2%

+180 days

-58.2%

Anchor price 6.01 on closest trading day on/after 2025-01-16. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on OnKure Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-27	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-04-07	SCHEDULE 13D	AI Biotechnology LLC	19.99%	9,091,532	view →
2024-10-08	SC	New Enterprise Associates 15, L.P.	—	—	view →
2023-05-30	SC	RiverVest Venture Fund III, L.P.	—	—	view →
2022-01-27	SC	Novo Holdings A/S	—	—	view →

Other Filings by RiverVest Venture Fund III, L.P.

Filed	Form	Issuer	Stake	Shares
2025-01-10	SCHEDULE	SPRUCE BIOSCIENCES, INC. SPRB	4.20%	1,759,521	view →
2023-05-30	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2023-05-30	SC	Reneo Pharmaceuticals, Inc. OKUR	—	—	view →
2021-01-08	SC	Allakos Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →